Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-03-11 @ 2:10 AM
Study NCT ID:
NCT02300558
Status:
TERMINATED
Last Update Posted:
2018-01-12
First Post:
2014-11-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12-17
Start Date Type:
ACTUAL
Primary Completion Date:
2016-12-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02-15
Completion Date Type:
ACTUAL
First Submit Date:
2014-11-21
First Submit QC Date:
None
Study First Post Date:
2014-11-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-12-12
Results First Submit QC Date:
None
Results First Post Date:
2018-01-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-12
Last Update Post Date:
2018-01-12
Last Update Post Date Type:
ACTUAL